Citations made to U.S. granted patents by U.S. patents granted in 2022

Specific WIPO fields: [ Computer technology  |  Digital communication  |  Electrical machinery, apparatus, energy  |  Measurement  |  Audio-visual technology  |  Medical technology  |  Optics  |  Transport  |  Semiconductors  |  Telecommunications  |  Other special machines  |  Pharmaceuticals  |  Organic fine chemistry  |  Mechanical elements  |  Chemical engineering  |  Engines, pumps, turbines  |  Civil engineering  |  Control  |  Basic materials chemistry  |  Handling  |  Furniture, games  |  Machine tools  |  Biotechnology  |  Other consumer goods  |  Macromolecular chemistry, polymers  |  IT methods for management  |  Textile and paper machines  |  Basic communication processes  |  Surface technology, coating  |  Materials, metallurgy  |  Environmental technology  |  Thermal processes and apparatus  |  Analysis of biological materials  |  Food chemistry  |  Micro-structural and nano-technology ]

Antibody-Based Therapeutics: A significant portion of the highly cited patents focuses on antibody engineering and production. This includes the development of humanized antibodies, recombinant antibodies, and transgenic animals for antibody production. These advancements have revolutionized the field of biopharmaceuticals, leading to the development of numerous therapeutic antibodies for the treatment of various diseases.

Drug Delivery Systems: Patents related to liposomal formulations and drug delivery systems highlight the importance of effective drug delivery in improving therapeutic outcomes. These technologies enable targeted delivery of drugs to specific tissues or cells, reducing side effects and enhancing efficacy.

Small Molecule Therapeutics: Patents related to small molecule compounds, such as norastemizole polymorphs, indicate ongoing research and development in the field of small molecule drug discovery. These compounds offer potential therapeutic benefits for a wide range of diseases.

CRISPR-Cas9 Gene Editing: The inclusion of a patent related to CRISPR-Cas9 gene editing technology underscores the significant impact of this revolutionary technology on the field of pharmaceuticals. This technology has the potential to revolutionize the treatment of genetic diseases.

Overall, the top cited patents in pharmaceuticals reflect the rapid advancements in biotechnology, drug discovery, and delivery systems. These innovations have the potential to improve human health and address unmet medical needs.

#pharmaceuticals #biotechnology #drugdiscovery #antibodies #geneediting #drugdelivery #innovation #healthcare

  1. 14 5595756    Liposomal compositions for enhanced retention of bioactive agents
  Inventors:  Marcel B. Bally; Nancy L. Boman; Pieter R. Cullis; Lawrence D. Mayer

  2. 11 6180370    Humanized immunoglobulins and methods of making the same
  Inventors:  Cary L. Queen; Harold E. Selick

  3. 9 10624902    Dietary supplement
  Inventors:  James Peter Morrissette

  3. 9 9334331    Bispecific antibodies
  Inventors:  Tomoyuki Igawa; Zenjiro Sampei; Tetsuo Kojima; Tetsuhiro Soeda; Atsushi Muto; Takehisa Kitazawa; Yukiko Nishida; Chifumi Imai; Tsukasa Suzuki; Kazutaka Yoshihashi

  5. 8 7745391    Human thrombospondin polypeptide
  Inventors:  Liat Mintz; Hanqing Xie; Dvir Dahary; Erez Levanon; Shiri Freilich; Nili Beck; Wei-Yong Zhu; Alon Wasserman; Jeanne Bernstein

  6. 7 10858467    Conducting polymer, 1-octadecene, polymer with 2,5 furnadione, metal salts
  Inventors:  Joseph Laurino

  6. 7 10858468    Polymer, 1-octadecene, polymer with 2,5 furandione, metal salts used to make electronic components
  Inventors:  Joseph Laurino

  6. 7 10865265    Polymer, 1-octadecene, polymer with 2,5 furandione, metal salts used as a catalyst means
  Inventors:  Joseph Laurino

  9. 6 10421807    Interleukin-31 monoclonal antibody
  Inventors:  Andrea Joy Gonzales; Gregory Fici; Gary Francis Bammert; Steven Alan Dunham

  9. 6 6627646    Norastemizole polymorphs
  Inventors:  Roger P. Bakale; Chris Senanayake; Yaping Hong; Kostas Saranteas; Martin P. Redmon; Stephen A. Wald

  9. 6 7112660    Modified cytokine
  Inventors:  Helena Domingues; Hartmut Oschkinat; Luis Serrano; Joerg Peters

  9. 6 9637739    RNA-directed DNA cleavage by the Cas9-crRNA complex
  Inventors:  Virginijus Siksnys; Giedrius Gasiunas; Tautvydas Karvelis

  1. 219 4816567    Recombinant immunoglobin preparations
  Inventors:  Shmuel Cabilly; Herbert L. Heyneker; William E. Holmes; Arthur D. Riggs; Ronald B. Wetzel

  2. 151 5585089    Humanized immunoglobulins
  Inventors:  Cary L. Queen; Harold E. Selick

  3. 116 8008449    Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
  Inventors:  Alan J. Korman; Mohan Srinivasan; Changyu Wang; Mark J. Selby; Bingliana Chen; Josephine M. Cardarelli

  4. 107 5545806    [T]Ransgenic non-human animals for producing heterologous antibodies
  Inventors:  Nils Lonberg; Robert M. Kay

  5. 98 5693762    Humanized immunoglobulins
  Inventors:  Cary L. Queen; Man Sung Co; William P. Schneider; Nicholas F. Landolfi; Kathleen L. Coelingh; Harold E. Selick

  6. 97 5225539    Recombinant altered antibodies and methods of making altered antibodies
  Inventors:  Gregory P. Winter

  6. 97 5569825    Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
  Inventors:  Nils Lonberg; Robert M. Kay

  8. 96 6737056    Polypeptide variants with altered effector function
  Inventors:  Leonard Presta

  9. 95 5821337    Immunoglobulin variants
  Inventors:  Paul J. Carter; Leonard G. Presta

  10. 94 5633425    Transgenic non-human animals capable of producing heterologous antibodies
  Inventors:  Nils Lonberg; Robert M. Kay

References:
Raw data from: U.S. Patent and Trademark Office. "Data Download Tables." PatentsView. Accessed September 7, 2024. https://patentsview.org/download/data-download-tables.

Please contact me (carlos@candeloro.net) for methodology, or if you know or believe information presented is not correct.